
浏览全部资源
扫码关注微信
纸质出版:2016
移动端阅览
张家华,季惠翔,包国华,周占松,周远秀,支轶,郎朗.经尿道保留尿道前壁前列腺剜除术的前瞻性随机双盲对照研究[J].陆军军医大学学报(原第三军医大学学报),2016,38(03):297-301.
Zhang Jiahua,Ji Huixiang,Bao Guohua,Zhou Zhansong,Zhou Yuanxiu,Zhi Yi,Lang Lang.Transurethral ventral preserving enucleation of the prostate: a prospective, randomized, double-blind and controlled study[J].J Amry Med Univ (J Third Mil Med Univ),2016,38(03):297-301.
张家华,季惠翔,包国华,周占松,周远秀,支轶,郎朗.经尿道保留尿道前壁前列腺剜除术的前瞻性随机双盲对照研究[J].陆军军医大学学报(原第三军医大学学报),2016,38(03):297-301. DOI:
Zhang Jiahua,Ji Huixiang,Bao Guohua,Zhou Zhansong,Zhou Yuanxiu,Zhi Yi,Lang Lang.Transurethral ventral preserving enucleation of the prostate: a prospective, randomized, double-blind and controlled study[J].J Amry Med Univ (J Third Mil Med Univ),2016,38(03):297-301. DOI:
目的 比较经尿道保留尿道前壁前列腺剜除术(transurethral ventral preserving enucleation of the prostate,TUVPEP)与经尿道前列腺电切术(transurethral resection of the prostate,TURP)治疗良性前列腺增生患者的安全性、效果和严重并发症。 方法 200例良性前列腺增生(benign prostatic hyperplasia,BPH)患者,按照前列腺体积大小分为两层,M层为中大前列腺(45~80 g),L层为巨大前列腺(>80 g),每层按随机数字表分为2组。M1组和L1组为试验组,M2组和L2组为对照组。试验组采用作者专利器械“张氏多功能前列腺手术镜”进行TUVPEP,简称张氏前列腺剜除术(Zhang’s enucleation of the prostate,ZSEP),对照组进行TURP,统计手术持续时间、术中出血量、术后住院时间。出院后6个月随访,比较两组国际前列腺症状评分(IPSS)、生活质量评分(QOL)、最大尿流率(Q
max
)及严重并发症。采用SPSS 18.0统计软件进行分析,其中连续变量采用x-±s表示,两组间比较采用t检验。 结果 179例得到随访,试验组出血量显著少于对照组[M1组(27.63±20.35)mL与M2组(31.82±17.35)mL,P0.05;L1组(58.35±49.79)mL与L2组(73.39±43.78)mL,P0.05
]
。试验组住院时间显著缩短[M1组(3.80±1.03)d与M2组(6.61±1.91)d,P0.01;L1组(4.06±1.29)d与L2组(5.94±1.84)d,P0.01
]
。试验组术后Q
max
显著高于对照组[M1组(21.10±7.56)mL/s与M2组(16.10±5.94)mL/s,P0.01;L1组(25.70±9.18)mL/s与L2组(16.20±5.01)mL/s,P0.01
]
;试验组与对照组严重并发症分别为10%与21%,再次手术率分别为0%与6%,差异有统计学意义(P0.05)。 结论 与TURP比较,ZSEP显著减少出血量和手术时间,提高尿流率和减少严重并发症的发生,再次手术率极低,可缩短留置导尿时间和住院时间。
Objective To compare the safety
efficacy and
incidence of severe complications of transurethral ventral preserving enucleation of the prostate (TUVPEP) with transurethral resection of the prostate (TURP). Methods Two hundred patients with benign prostatic hyperplasia (BPH) admitted in our institute from April 2010 to April 2015 were prospectively recruited in this study. According to the size of the prostate
they were divided into M (the prostate in weight of 45~80 g) and L (80 g ) groups. Every group was further randomly divided into 2 subgroups to respectively undergoing TUVPEP (M1 and L1) or TURP (M2 and L2). Our patent Zhang’s multifunctional resectoscope was employed in TUVPEP (also named as Zhang’s enucleation of the prostate). The operative time
intra-operative bleeding volume
and post-operative hospital stay were recorded. International prostate sympathetic score (IPSS)
score of quality of life (QOL)
maximum flow rate (Q
max
)
urethral functional length (UFL)
urethral functional area (UFA) and incidences of severe complications were investigated in 6 month after operation
and the results were compared between the 2 operative approaches. Results A total of 179 patients completed the 6-month postoperative follow-up. Blood loss was lesser in those receiving TUVPEP than TURP during the operation (M: 27.63±20.35 vs 31.82±17.35 mL
P0.05; L: 58.35±49.79 vs 73.39±43.78 mL
P0.05)
and the durations of postoperative hospitalization was also short in the first approach than the latter (M: 3.80±1.03 d vs 6.61±1.91 d
P0.01; L: 4.06±1.29 d vs 5.94±1.84 d
P0.001). Postoperative Q
max
was obviously high in the former than the latter (M: 21.10±7.56 vs 16.10±5.94 mL/s
P0.01; L: 25.70±9.18 vs 16.20±5.01 mL/s
P0.01). The incidences of severe complications were lower in the former than the latter approaches (10% vs 21%)
and so was the re-operative rate (0% vs 6%). Conclusion Compared to TURP
our Zhang’s enucleation of the prostate has significantly smaller blood loss and shorter operation time
obviou
sly improves Q
max
and reduces the incidence of severe complications
decreases the re-operative rate
and shortens the times of indwelling catheter and hospital stay.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621